This analysis leverages public data and primary research including multiple surveys with Contract Development and Manufacturing Organizations (CDMOs) and interviews with industry executives. Despite experiencing vulnerability to the pandemic, the medical device and CDMO industries are positioned to perform strongly in 2021.
This analysis leverages public data and primary research including multiple survey with Cardiovascular, orthopedics and imaging were the most impacted sectors in 2020, as opposed to in-vitro diagnostics, critical and respiratory care and hospital consumables, whose demand got a boost from the new hospital protocols.Download Full Report
The healthcare emergency has required hospitals to prioritize treatment and prevention of COVID-19 patients during all of 2020 and into Q1 of 2021. This has caused a dramatic decline in volumes of elective procedures, with a large impact on the global industry revenue.Download Full Report
The COVID effect on the medical device industry is visible in the performance of the largest OEMs. Businesses more oriented to elective procedures suffered declining sales in 2020. Others, active in the markets for diagnostics and treatment of COVID-19, had a revenue boost.Download Full Report